UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Kolmar CEO steps down, apologizes for controversial video
by Lee Han-soo
2019-08-12 11:11
Kolmar apologizes for playing controversial YouTube clip
by Lee Han-soo
2019-08-09 16:48
Diabetes drug Jardiance pressures heart failure treatment Entresto
by Kim Yun-mi
2019-08-09 15:44
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial
by Lee Han-soo
2019-08-08 16:48
‘CPhI Korea thriving on local firms’ zeal for drug export’
by Jeong Sae-im
2019-08-08 14:54
라인
Hanmi’s US partner unveils P3 data on oral anticancer drug
by Lee Han-soo
2019-08-08 14:53
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
by Lee Han-soo
2019-08-07 16:22
Lilly’s anticancer combo drug nears getting insurance benefit
by Kim Yun-mi
2019-08-07 15:44
Lilly reports improved survival for Verzenio in P3 trial
by Lee Han-soo
2019-08-07 12:06
ISU Abxis to unveil p1 results for anticancer treatment in Europe
by Lee Han-soo
2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
by Lee Han-soo
2019-08-06 17:20
Japanese firms fear boycott may hurt prescription drug sales
by Kim Yun-mi
2019-08-06 15:44
Sillajen cites salvation therapy as reason for trial suspension advice
by Lee Han-soo
2019-08-06 15:43
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
by Lee Han-soo
2019-08-06 13:50
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
by Lee Han-soo
2019-08-05 17:02
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
by Lee Han-soo
2019-08-05 16:01
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
by Kim Yun-mi
2019-08-05 15:37
Helixmith unveils results for neuromuscular disease treatment
by Lee Han-soo
2019-08-02 17:52
‘MSD Korea playing tricks to maintain monitoring on salespersons’
by Kim Yun-mi
2019-08-02 15:48
Conflict erupts between employees of Takeda, Shire during merger
by Kim Yun-mi
2019-08-02 14:23
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top